HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype

Overview

Journal Cancer Res

Specialty Oncology

Date 2023 Jan 4

PMID 36598365

Authors

Man Xu

Ming Sun

Xiyuan Zhang

Rosa Nguyen

Haiyan Lei

Jack F Shern

Carol J Thiele

Zhihui Liu

Affiliations

Soon will be listed here.

Abstract

Significance: HAND2 and MYCN compete with nucleosomes to regulate global gene transcription and to drive a malignant neuroblastoma phenotype.

Citing Articles

Molecular principles underlying aggressive cancers.

Nussinov R, Yavuz B, Jang H Signal Transduct Target Ther. 2025; 10(1):42.

PMID: 39956859 PMC: 11830828. DOI: 10.1038/s41392-025-02129-7.

Fine construction of gene coexpression network analysis using GTOM and RECODE detected a critical module of neuroblastoma stages 4 and 4S.

Nakamura F, Nakano Y, Yamada S Hereditas. 2024; 161(1):44.

PMID: 39538286 PMC: 11562103. DOI: 10.1186/s41065-024-00342-y.

Targeting SWI/SNF ATPases reduces neuroblastoma cell plasticity.

Xu M, Hong J, Zhang X, Sun M, Liu X, Kang J EMBO J. 2024; 43(20):4522-4541.

PMID: 39174852 PMC: 11480351. DOI: 10.1038/s44318-024-00206-1.

Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activity.

Aljouda N, Shrestha D, DeVaux C, Olsen R, Alleboina S, Walker M Mol Oncol. 2024; 19(3):808-824.

PMID: 39119816 PMC: 11887674. DOI: 10.1002/1878-0261.13714.

Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation.

Banerjee D, Bagchi S, Liu Z, Chou H, Xu M, Sun M Nat Commun. 2024; 15(1):3432.

PMID: 38653778 PMC: 11039666. DOI: 10.1038/s41467-024-47166-y.

References

Moyle-Heyrman G, Tims H, Widom J . Structural constraints in collaborative competition of transcription factors against the nucleosome. J Mol Biol. 2011; 412(4):634-46. PMC: 3534743. DOI: 10.1016/j.jmb.2011.07.032. View

Otto T, Horn S, Brockmann M, Eilers U, Schuttrumpf L, Popov N . Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell. 2008; 15(1):67-78. DOI: 10.1016/j.ccr.2008.12.005. View

Gryder B, Pomella S, Sayers C, Wu X, Song Y, Chiarella A . Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma. Nat Genet. 2019; 51(12):1714-1722. PMC: 6886578. DOI: 10.1038/s41588-019-0534-4. View

van Groningen T, Koster J, Valentijn L, Zwijnenburg D, Akogul N, Hasselt N . Neuroblastoma is composed of two super-enhancer-associated differentiation states. Nat Genet. 2017; 49(8):1261-1266. DOI: 10.1038/ng.3899. View

Reiter F, Wienerroither S, Stark A . Combinatorial function of transcription factors and cofactors. Curr Opin Genet Dev. 2017; 43:73-81. DOI: 10.1016/j.gde.2016.12.007. View

Cheung N, Dyer M . Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer. 2013; 13(6):397-411. PMC: 4386662. DOI: 10.1038/nrc3526. View

Bushweller J . Targeting transcription factors in cancer - from undruggable to reality. Nat Rev Cancer. 2019; 19(11):611-624. PMC: 8820243. DOI: 10.1038/s41568-019-0196-7. View

Bradner J, Hnisz D, Young R . Transcriptional Addiction in Cancer. Cell. 2017; 168(4):629-643. PMC: 5308559. DOI: 10.1016/j.cell.2016.12.013. View

McLean C, Bristor D, Hiller M, Clarke S, Schaar B, Lowe C . GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010; 28(5):495-501. PMC: 4840234. DOI: 10.1038/nbt.1630. View

10.

Harmelink C, Peng Y, DeBenedittis P, Chen H, Shou W, Jiao K . Myocardial Mycn is essential for mouse ventricular wall morphogenesis. Dev Biol. 2012; 373(1):53-63. PMC: 3508168. DOI: 10.1016/j.ydbio.2012.10.005. View

11.

Sanchez G, Richmond P, Bunker E, Karman S, Azofeifa J, Garnett A . Genome-wide dose-dependent inhibition of histone deacetylases studies reveal their roles in enhancer remodeling and suppression of oncogenic super-enhancers. Nucleic Acids Res. 2017; 46(4):1756-1776. PMC: 5829637. DOI: 10.1093/nar/gkx1225. View

12.

Orlando D, Chen M, Brown V, Solanki S, Choi Y, Olson E . Quantitative ChIP-Seq normalization reveals global modulation of the epigenome. Cell Rep. 2014; 9(3):1163-70. DOI: 10.1016/j.celrep.2014.10.018. View

13.

Boeva V, Louis-Brennetot C, Peltier A, Durand S, Pierre-Eugene C, Raynal V . Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat Genet. 2017; 49(9):1408-1413. DOI: 10.1038/ng.3921. View

14.

Meyer N, Penn L . Reflecting on 25 years with MYC. Nat Rev Cancer. 2008; 8(12):976-90. DOI: 10.1038/nrc2231. View

15.

Ramirez F, Ryan D, Gruning B, Bhardwaj V, Kilpert F, Richter A . deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016; 44(W1):W160-5. PMC: 4987876. DOI: 10.1093/nar/gkw257. View

16.

Brockmann M, Poon E, Berry T, Carstensen A, Deubzer H, Rycak L . Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell. 2013; 24(1):75-89. PMC: 4298657. DOI: 10.1016/j.ccr.2013.05.005. View

17.

Wang L, Tan T, Durbin A, Zimmerman M, Abraham B, Tan S . ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry. Nat Commun. 2019; 10(1):5622. PMC: 6901540. DOI: 10.1038/s41467-019-13515-5. View

18.

Puissant A, Frumm S, Alexe G, Bassil C, Qi J, Chanthery Y . Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013; 3(3):308-23. PMC: 3672953. DOI: 10.1158/2159-8290.CD-12-0418. View

19.

Khan A, Mathelier A . Intervene: a tool for intersection and visualization of multiple gene or genomic region sets. BMC Bioinformatics. 2017; 18(1):287. PMC: 5452382. DOI: 10.1186/s12859-017-1708-7. View

20.

Sabo A, Kress T, Pelizzola M, de Pretis S, Gorski M, Tesi A . Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature. 2014; 511(7510):488-492. PMC: 4110711. DOI: 10.1038/nature13537. View